glp-1 and chronic kidney disease Receptor Agonists Protection glp1 #gip #semaglutide #tirzepatide #liraglutide

The exact duration depends on the individual, the type and dose of medication they take, and how quickly they increase their GLP-1 dose

Clinical studies have demonstrated substantial weight reduction in participants using Tirzepatide, which opens up exciting possibilities for its application as an anti-obesity treatment

For athletes, this appetite suppression can inadvertently lower total protein consumption and overall energy availabilitytwo factors critical for maintaining lean muscle mass during training

Unlike semaglutide, which targets GLP-1 only, or tirzepatide (GLP-1 + GIP), Retatrutide adds glucagon receptor activity that increases resting energy expenditure, a mechanism not present in either predecessor

A deficiency can, therefore, lead not only to the central nervous system manifestations seen in Wernicke encephalopathy but also to peripheral sensorimotor neuropathy, characterized by weakness, numbness, and pain in the extremities